alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
The following table sets forth the Company's financial results for the
nine month period ending September 30, 1998 and 1997.
<TABLE>
Unaudited Consolidated Statement of Income

<CAPTION>
             CONSOLIDATED STATEMENT OF INCOME)
     Three months ending Sep 30    Nine months ending Sep 30

<S>                    <C>          <C>           <C>            <C>
                       1998         1997          1998           1997
Total Revenue         $503,442     $464,079      $1,176,013     $1,520,869
Cost of Goods          303,230      276,077         746,230      1,009,465
Gross Profit           200,212      188,002         429,783        511,404
S,G,&A Expense         147,933      153,308         457,619        435,737
Operating Income(Loss)  52,279       34,694         (27,836)        75,667
Other Income (Expense) (13,156)      35,208          (8,516)        83,244                
  Interest Expense      11,859       11,123          36,321         38,802
Net Income (Loss)      $27,264      $58,779        ($72,673)      $120,109
Shares Outstanding  22,977,975   22,218,881      22,977,975     22,218,881
Earnings Per Share        .001         .003           (.003)         (.005)
</TABLE>
     
Both sales and costs were about the same for the third quarter in both
years.  Higher net income in 1997 was due primarily to the receipt in the
1997 quarter of $50,000 of non-operating income which was not repeated in
the 1998 quarter.

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.


                                              TVI CORPORATION

                                              /s/Allen E. Bender

                                              Allen E. Bender, President

                                              October 27, 1998
EXHIBIT 10.12

 

CASH COMPENSATION ARRANGEMENTS WITH NON EMPLOYEE DIRECTORS

 

Annual Retainer*:

 

	
Board Members
    	
 
    	
$
    	
25,000
    	
 
    
	
Chairman of the Board (additional)
    	
 
    	
$
    	
15,000
    	
 
    
	
Audit Committee Chairperson (additional)
    	
 
    	
$
    	
7,500
    	
 
    
	
Compensation Committee Chairperson (additional)
    	
 
    	
$
    	
5,000
    	
 
    
	
Corporate Governance and Nominating Committee   Chairperson (additional)
    	
 
    	
$
    	
5,000
    	
 
    


 




*  Paid quarterly in arrears.

 

Meeting Fees:

 

	
Board of Directors
    	
 
    	
 
    	
 
    
	
Annual offsite regular meeting
    	
 
    	
$
    	
2,500
    	
 
    
	
Regular meeting
    	
 
    	
$
    	
1,000
    	
 
    
	
Special (telephonic)
    	
 
    	
$
    	
500
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
Audit Committee
    	
 
    	
 
    	
 
    
	
Regular meeting
    	
 
    	
$
    	
2,500
    	
 
    
	
Special (in person)
    	
 
    	
$
    	
1,000
    	
 
    
	
Special (telephonic)
    	
 
    	
$
    	
750
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
Compensation Committee
    	
 
    	
 
    	
 
    
	
Regular meeting
    	
 
    	
$
    	
2,000
    	
 
    
	
Special
    	
 
    	
$
    	
750
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
Corporate Governance and Nominating Committee
    	
 
    	
 
    	
 
    
	
Regular meeting
    	
 
    	
$
    	
2,000
    	
 
    
	
Special
    	
 
    	
$
    	
750
IN THE SUPREME COURT OF PENNSYLVANIA 

In the Matter of 

ROMA S. YOUNG 

PETITION FOR REINSTATEMENT 

FROM ADMINISTRATIVE SUSPENSION 

: 

: 

: 

: 

: 

: 

: 

No. 173 DB 2014 (No. 5 RST 2015) 

Attorney Registration No. 29064 

(Delaware County) 

O R D E R 

PER CURIAM 

AND NOW, this 15th day of January, 2015, the Report and Recommendation of 

Disciplinary Board Member dated January 6, 2015, is approved and it is ORDERED that 

Roma S. Young, who has been on Administrative Suspension , has never been 

suspended or disbarred, and has demonstrated that she has the moral qualifications, 

competency and learning in law required for admission to practice in the 

Commonwealth, shall be and is, hereby reinstated to active status as a member of the 

Bar of this Commonwealth. The expenses incurred by the Board in the investigation 

and processing of this matter shall be paid by the Petitioner.
--- ---- REF ID:A67339 

·-

Prot'ttalOr 8•uol s .. Wllk• 

Dipan$t or Kat.Peutl.•• 

lo1! 7o81 Filla Dall 

PJ"lftff to:i \.zd. TGrA\y 

Mmetor:. lfw J•nzez 

hrl•lt \ ?...'a'ii. 

~+~LI\, '"'S"'3 

.Pleu6 accw;it oltt 81"p?'fd.at1'!ln ot JUmt ooopr.ra.ttan 1n ""-"ll~•Ullg 

all. titM!I oamr.J.3 dot.13.• ~u.t:r.'1 bJ u,., achlnbtl'aU.Te p:n:ice!t1U"es 11\ 

\be OCC4A1.cn er r.?_JZ la.~'\ Tir.t,.t t..o t.he ~y. !'t14 M.rcV.i- extetds 

11.b &p~lOQ ft>~ Ill. the iact·nftn.t.¥?•~ Cll't.l!tM ltf \~Pl pro:Gd.Jt89 ad 

111eblta t.. Pi<Nlle hi., \hades t=- tile ~..,t Ntux'n ot ''- o:iJ!IPl•t.ed 

Nr.JOYJal lii•tor1 :a.at..isrr~t .. 

l • ..U~ ,o-a hereJlth a. •J.iJi1flcaU.~n o.t P9r1<1nool -'oti.on" 

•a'!.it'f; v1 t.h )!Ol.il' a.~po1nt.annt. as a 9.Pl01a1 eon1J\1l.tant.. Thi• i• ~ !w JOlU' Ales el zte~u!Na no ast.tcn on J'DA.J' paJl't.. Tba data 

rader •i«t&tlc•" .ro U.,:ce beoll~.1• ot .n&tlltor'J' .NQ.'dr•ente. Jut 

PQ" M attction to tba. 

l=l• 

1n1.t1 u Uml ot 

Pvoonnel .AcUm 

COi AO 

C/S 

S/ASST. 

SEC 

.a. •· WllVm Mu" Aalr:al, us ...,. 1;1.co Mraa.t.cc- . 

R/D (Dr. lAlbler) 

M/Rs Pro£. Wilka is a mombor or the ISA.'SAB.. Ltr pl't'.tpa1"8d at 

Admiral. Wqer•a direot.ion. 

Rq H. Io\JJJVJ Capt, Sig c/6o2Sl/ll Kar Sl 

Ra'ri.aed DJS William F. 1rledman/S/ASST/6o'li;)/l7 Har )l 

@'pproved for Release bv NSA on 06-20-2014 pursuant to E.O. 1352\3 ___ _ 

-
• REF ID:iJi9131 

.. 

BRITISH SECURITY CO-ORDINATION 

OIBOLB 8-0170 

BI SAFE HAND 

William F. Friedman Esq. 

Director or Communications Research, 

War Department, 

Arlington. 

Dear Mr. Friedman, 

828, l!'ll'TJI A. VKNUB 

(BOOK HO) 

NBW YORK. 20, N. Y. 

October 20th, 1943. 

Have just to-day returned .to this country and 

find that you were good enough to send me the schematic or that 

drawing on the 13th September, for which thank you very much. 

I hope that your family are well, and all at 

Station X send their very kindest regards, which I will give to you 

personally next time I am. in Washington. · · 

·Yours sincerely, (. ') cl' *' )( -\· ' \ d .. ~"' ~I ~· .J - • 1! • - • --·- "J 

B. deF. Bqly, 

Assistant Director/Communications. 

@'pproved for Release by NSA on 03-27-2014 pursuant to E.O. 1352e
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 13-6636

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

v.

PAUL BERNARD MITCHELL, JR.,

Defendant - Appellant.

Appeal from the United States District Court for the Eastern 

District of North Carolina, at Raleigh. Malcolm J. Howard, 

Senior District Judge. (5:09-cr-00382-H-1; 5:12-cv-00471-H)

Submitted: July 25, 2013 Decided: July 30, 2013

Before GREGORY, DAVIS, and THACKER, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Paul Bernard Mitchell, Jr., Appellant Pro Se. Jennifer P. MayParker, Assistant United States Attorney, Raleigh, North 

Carolina, for Appellee.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Paul Bernard Mitchell, Jr., seeks to appeal the 

district court’s order dismissing as untimely his 28 U.S.C.A.

§ 2255 (West Supp. 2013) motion. The order is not appealable 

unless a circuit justice or judge issues a certificate of 

appealability. 28 U.S.C. § 2253(c)(1)(B) (2006). A certificate 

of appealability will not issue absent “a substantial showing of 

the denial of a constitutional right.” 28 U.S.C. § 2253(c)(2) 

(2006). When the district court denies relief on procedural 

grounds, the prisoner must demonstrate both that the dispositive 

procedural ruling is debatable, and that the motion states a 

debatable claim of the denial of a constitutional right. 

Slack v. McDaniel, 529 U.S. 473, 484-85 (2000). 

We have independently reviewed the record and conclude 

that Mitchell has not made the requisite showing. Accordingly, 

we deny a certificate of appealability and dismiss the appeal. 

We dispense with oral argument because the facts and legal 

contentions are adequately presented in the materials before 

this court and argument would not aid the decisional process. 

DISMISSED
# ORIGINAL IN THE SUPREME COURT OF THE STATE OF MONTANA DA 19-0220
STATE OF MONTANA,

Plaintiffand Appellee,
v. DESMOND D.HARDESTY,

Defendant and Appellant. 

### DEC 1 6 2020
Bowen Greenwood 

## cyi livi4 ,s 4z pre o m nt e a na ou rt

Counsel for Appellant Desmond D.Hardesty filed a motion and briefasking to be allowed to withdraw from this appeal on grounds that counsel has been unable to find any nonfrivolous issues to raise on appeal, pursuant to § 46-8-103(2), MCA,and Anders v. California, 386 U.S. 738,87 S.Ct. 1396 (1967). The argumentportion ofcounsel'sAnders briefdoes not satisfy the requirements of Anders and § 46-8-103(2), MCA,that counsel support the client's appeal to the best of counsel's ability and submit a memorandum referring to anything in the record that might arguably support the appeal. Here, counsel does not adequately identify the issues that arguably support an appeal,nor does counsel provide "appropriate citations to the record and to the pertinent statutes, case law, and procedural rules bearing upon each issue discussed in the memorandum"as § 46-8-103(2),MCA, requires. Along with other issues counsel may identify, the Court requests that counsel address the issue of whether the District Court erred in denying Hardesty's motion to dismiss the State's second petition for revocation. Accordingly, IT IS ORDERED that counsel's brief in support of her motion to withdraw is STRICKEN FROM THE RECORD 12/16/2020

Case Number: DA 19-0220IT IS FURTHER ORDERED that counsel shall have thirty days from the date of

this Order in which to file an Anders briefwhich complies with the requirements ofthat case and § 46-8-103(2), MCA,and refers to anything in the record that arguably might support Hardesty's appeal. The Clerk is directed to provide copies ofthis Order to all counsel ofrecord and to Hardesty personally. DATED this /6 4

' day ofDecember,2020.

For the Court,

ChiefJustice
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                          30,058
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                95,000
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                    562,065
<INVESTMENTS-CARRYING>                          15,490
<INVESTMENTS-MARKET>                            15,715
<LOANS>                                        565,745
<ALLOWANCE>                                     16,862
<TOTAL-ASSETS>                               1,300,629
<DEPOSITS>                                   1,135,163
<SHORT-TERM>                                    27,750
<LIABILITIES-OTHER>                             16,085
<LONG-TERM>                                     11,250
<COMMON>                                        46,846
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                      63,535
<TOTAL-LIABILITIES-AND-EQUITY>               1,300,629
<INTEREST-LOAN>                                 38,513
<INTEREST-INVEST>                               33,455
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                                71,968
<INTEREST-DEPOSIT>                              30,552
<INTEREST-EXPENSE>                              32,751
<INTEREST-INCOME-NET>                           39,217
<LOAN-LOSSES>                                    3,500
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                 19,619
<INCOME-PRETAX>                                 20,888
<INCOME-PRE-EXTRAORDINARY>                      20,888
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    13,951
<EPS-PRIMARY>                                     1.96
<EPS-DILUTED>                                     1.94
<YIELD-ACTUAL>                                    4.25
<LOANS-NON>                                     24,098
<LOANS-PAST>                                     7,448
<LOANS-TROUBLED>                                23,202
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                16,674
<CHARGE-OFFS>                                    5,077
<RECOVERIES>                                     1,765
<ALLOWANCE-CLOSE>                               16,862
<ALLOWANCE-DOMESTIC>                            16,862
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        

</TABLE>
<PAGE>   1


                                                                    EXHIBIT 23

CONSENT OF INDEPENDENT AUDITORS


We consent to the incorporation by reference in the Registration
Statements (Form S-8 No. 33-88716, Form S-8 No. 333-06003, Form S-3 No.
333-02846, Form S-3  No. 333-29797, Form S-3 No. 333-36089, Form S-3 No.
333-41731 and Form S-3  No. 333-56601) of our report, dated February 27, 1998,
except for paragraph 2 of  Note 14, as to which the date is May 15, 1998,
included in the Annual Report on  Form 10-K of Illinois Superconductor
Corporation for the year ended December  31, 1997, with respect to the
financial statements, as amended, included in  this Form 10-K/A.

                                                   /s/ Ernst & Young LLP
                                                   ---------------------
                                                       Ernst & Young LLP


Chicago, Illinois
July 31, 1998
<PAGE>

                                                                    EXHIBIT 12.1
                            CERTIFICATION PURSUANT TO
                SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002

I, Ronan O'Caoimh, certify that:

1. I have reviewed this annual report on Form 20-F of Trinity Biotech plc;

2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;

4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 15(d)-15(e)) for the registrant and we have:

a) designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this annual report is being prepared;

b) [RESERVED]

c) evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this annual report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this annual report based on such evaluation ; and

d) disclosed in this annual report any change in the registrant's internal
control over financial reporting that occurred during the period covered by this
annual report that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting.

5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the Audit Committee of the registrant's Board of
Directors (or persons performing the equivalent function):

a) all significant deficiencies and material weaknesses in the design or
operation of internal controls over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarise and report financial information; and

b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control over
financial reporting.

Date:  March 31, 2005

RONAN O'CAOIMH *
-----------------------
Ronan O'Caoimh
Chief Executive Officer

*  The originally executed copy of this Certification will be maintained at
the Company's offices and will be made available for inspection upon request.
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED JULY 13, 2018

NO. 03-17-00543-CV

Randal B. Ward, Appellant

v.

Suzanne Banowsky McCaskill, Appellee

APPEAL FROM THE 274TH DISTRICT COURT OF COMAL COUNTY

BEFORE CHIEF JUSTICE ROSE, JUSTICES GOODWIN AND FIELD

REVERSED AND REMANDED -- OPINION BY JUSTICE GOODWIN

This is an appeal from the judgment signed by the trial court on April 26, 2017. The parties have

filed an agreed motion to reverse and remand the case to the trial court. Having found that there 

was reversible error in the trial court’s judgment, the Court grants the parties’ motion, reverses

the trial court’s judgment, and remands the case to the trial court for further proceedings 

consistent with this Court’s opinion. The appellant shall pay all costs relating to this appeal, both 

in this Court and in the court below.
EXHIBIT 32.1

WRITTEN STATEMENT OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, the Chief Executive Officer and the Chief Financial Officer
of Biomet, Inc. (the "Company"), each hereby certifies that to his knowledge
on the date hereof:

(a)   The quarterly Report on Form 10-Q of the Company for the Quarter Ended
      November 30, 2005 filed on the date hereof with the Securities and
      Exchange Commission (the "Report") fully complies with the requirements
      of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(b)   Information contained in the Report fairly represents, in all material
      respects, the financial condition and results of operations of the
      Company.

                                                   /s/  Dane A. Miller
                                                   -------------------
                                                   Dane A. Miller, Ph.D.
                                                   January 9, 2006

                                                   /s/  Gregory D. Hartman
                                                   -----------------------
                                                   Gregory D. Hartman
                                                   January 9, 2006

The foregoing certification is being furnished to the Securities and Exchange
Commission as an exhibit to the Form 10-Q and shall not be deemed to be
considered filed as part of the Form 10-Q.
<TABLE> <S> <C>

<ARTICLE>                     5

<S>                           <C>
<PERIOD-TYPE>                 12-MOS
<FISCAL-YEAR-END>             DEC-31-1999
<PERIOD-START>                JAN-01-1999
<PERIOD-END>                  DEC-31-1999
<CASH>                        1,602,658
<SECURITIES>                  0
<RECEIVABLES>                 36,487,010
<ALLOWANCES>                  834,359
<INVENTORY>                   0
<CURRENT-ASSETS>              0
<PP&E>                        0
<DEPRECIATION>                0
<TOTAL-ASSETS>                37,634,909
<CURRENT-LIABILITIES>         0
<BONDS>                       0
<PREFERRED-MANDATORY>         572,942
<PREFERRED>                   0
<COMMON>                      0
<OTHER-SE>                    37,061,967
<TOTAL-LIABILITY-AND-EQUITY>  37,634,909
<SALES>                       0
<TOTAL-REVENUES>              4,426,245
<CGS>                         0
<TOTAL-COSTS>                 546,464
<OTHER-EXPENSES>              0
<LOSS-PROVISION>              408,890
<INTEREST-EXPENSE>            528,611
<INCOME-PRETAX>               2,942,280
<INCOME-TAX>                  0
<INCOME-CONTINUING>           2,942,280
<DISCONTINUED>                0
<EXTRAORDINARY>               0
<CHANGES>                     0
<NET-INCOME>                  2,942,280
<EPS-BASIC>                   .00
<EPS-DILUTED>                 .00



</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000351532
<NAME> INTERFERON SCIENCES, INC.
<MULTIPLIER> 1

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                         205,867
<SECURITIES>                                         0
<RECEIVABLES>                                  208,701
<ALLOWANCES>                                         0
<INVENTORY>                                    189,350
<CURRENT-ASSETS>                               718,748
<PP&E>                                      12,759,273
<DEPRECIATION>                               9,476,153
<TOTAL-ASSETS>                               4,247,024
<CURRENT-LIABILITIES>                        5,389,353
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        47,256
<OTHER-SE>                                 (1,189,585)
<TOTAL-LIABILITY-AND-EQUITY>                 4,247,024
<SALES>                                        986,187
<TOTAL-REVENUES>                               986,187
<CGS>                                        1,636,579
<TOTAL-COSTS>                                1,636,579
<OTHER-EXPENSES>                             3,204,065
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (3,849,080)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (3,849,080)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (3,849,080)
<EPS-BASIC>                                    (.83)
<EPS-DILUTED>                                    (.83)


</TABLE>
<PAGE>   1

                                                                    EXHIBIT 23.1




               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS

We have issued our report dated January 12, 2001, except for the final section
of Note 12 and for Note 13, as to which the dates are February 26, 2001, and
March 19, 2001, respectively, on the consolidated balance sheet of Illinois
Superconductor Corporation and subsidiaries as of December 31, 2000, and the
related statements of operations, changes in stockholders' equity, and cash
flows of Illinois Superconductor Corporation for the year ended December 31,
2000, included in its Annual Report on Form 10-K for the year ended December 31,
2000 filed with the Securities and Exchange Commission. We hereby consent to the
incorporation by reference of our report in the Registration Statements on Form
S-3 (File numbers 333-53338 and 333-53646) and Form S-8 (File numbers 333-39342
and 333-49268).


                                           /s/ GRANT THORNTON LLP

Chicago, Illinois
March 29, 2001